您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Novartis Capital
LEI 5493002KF87V5RSRQS84

机构名称
Novartis Capital Corporation
国家名称
瑞士
注册登记国
美国
行业
药品生产和生物技术
债券负债
1.000 百万 USD

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件
请求访问

最新数据在

卖价

查询已发送
无法访问
发送查询
信息提供者所提供的报价仅供参考。

简介

Novartis Capital Corporation is a finance subsidiary indirectly owned 100% by Novartis AG and was incorporated as a corporation under the laws of Delaware on July 23, 2008. It exists for the purpose of issuing debt securities, the proceeds of which will be invested by it in marketable securities or advanced to, or otherwise invested in, subsidiaries or affiliates of Novartis AG.

奖项

新闻

2024-02-19 Moody's Investors Service upgrades LT- local currency credit rating of Novartis Capital to "Aa3" from "A1"; outlook stable
2023-02-13 Moody's Investors Service revised outlook on Novartis Capital to positive and affirmed at "A1" (LT- local currency) credit rating
2021-11-08 Moody's Investors Service affirms Novartis Capital at "A1" (LT- local currency credit rating); outlook stable
2019-11-27 Moody's Investors Service affirms Novartis Capital at "A1" (LT- local currency credit rating); outlook stable
2018-07-03 Moody's Investors Service downgrades LT- local currency credit rating of Novartis Capital to "A1"; outlook stable
所有机构分析

相关文件

关联机构

股票

最近一次的发行

全部显示

发行人的分类·

  • Organization does not disclose IFRS/US GAAP financial statements

债券负债 (按货币)

显示所有 隐藏

代码

  • LEI
    5493002KF87V5RSRQS84
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001443411

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权